JT
PRAX icon

Jupiter Topco’s Praxis Precision Medicines PRAX Stock Holding History

Jupiter Topco’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15B Buy
+3,421,374
New +$1.08B 0.47% 40

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Topco's PRAX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 3,421,374 shares worth $1.15B. The stake represents 0.47% of the portfolio and ranks #40 among its holdings.

281 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Jupiter Topco held 3,421,374 shares of Praxis Precision Medicines worth $1.15B as of Q2 2026.
  • Praxis Precision Medicines was a new Jupiter Topco position in Q2 2026.
  • Praxis Precision Medicines made up 0.47% of Jupiter Topco's portfolio in Q2 2026, its #40 holding.
  • 281 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.